In Other News

• UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

• Noninvasive AI-Enabled Raman Probe Distinguishes Skin Cancers from Normal Tissue

• Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

• Expanded Partnership Supports AI Biomarker Validation and Clinical Trial Deployment

• World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

• Routine Newborn Blood Spots Can Measure GBS Antibody Levels

• Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions

• Facilitated Cascade Program Increases Genetic Testing in Hereditary Cancer Families

• Magnetically Guided Capsule Enables Targeted Small Intestine Microbiome Sampling

• Urine-Based RNA Improves Bladder Cancer Detection and Monitoring

• Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy

• Blood RNA Panel Predicts Lung Cancer Risk Years Before Diagnosis

• Bile DNA Testing Detects Tumor Signals Before Conventional Cancer Diagnosis

• New Blood Test Could Help Predict Severe Scoliosis in Adolescents

• Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

• Genomic Classifier Predicts Benefit From Adding Hormone Therapy to Salvage Prostate Radiation

• Global Survey Underscores Need to Standardize Bone Biomarker Testing

• Blood-Based Test Broadens Colorectal Cancer Screening Options

• Screening After Pneumococcal Infection May Reveal Undiagnosed Blood Cancer or Immune Disorders

• Screening After Pneumococcal Infection May Reveal Undiagnosed Blood Cancer or Immune Disorders

• Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis

• Rapid D-Dimer Assay Supports Exclusion and Monitoring of Serious Clotting Conditions

• RNA Splicing Assays Improve Classification of Inherited Disease Variants